Tài liệu, văn bản bạn tìm kiếm
PKCδ activators, B lymphoma, Immunohistochemical criteria, Calcium and magnesium, Oxaliplatin-induced neurotoxicity, Primary keratinocytes, Lentiviral mediated gene transduction, Average celebrities, Annexin A7, Gene transfection, Animal experiment, Capsule rupture, Tumorigenesis remains controversial, Tumor-progressing factors, Prolyl hydroxylase enzymes, Asparaginyl hydroxylase, Cell stress response, Metastatic triple negative, Nuclear caspase-8, Pleural cancer, Tumor dedifferentiation, Mesothelioma mortality, Normal hepatocytes, Anti-gas masks, TRAIL receptor 1, TLR3 pathwaysynergist, Produce therapeutic, IGF-1R inhibitor, Population-based cohort study, Diffuse optical imaging, Human colorectal carcinomas, Total hemoglobin, Apparent diffusion coefficients, Genetic associations, Diffuse thyroid disease, Adipose tissue-derived mesenchymal stromal cells, T-cell malignancies, Multifunctional membrane protein, T-cell biology, Time from diagnosis to surgery, Survival inequalities, Pro-oncogenic pathways, Serrated adenomas, Platinum-sensitive patients, Glutamate acid decarboxylase 1, Virtually non-existent, Promoter occupancy, Genetically activated BRAF, Sequence-specific transcription factor, Metastatic melanoma harboring, STR profiling, Cutaneous metastases, Co-immunoprecipitation, Therapeutic problem, Disease-related outcomes, Fusion protein expression, Elective treatments, Antineoplastic drug treatment, Biochemical failure-free survival, Epitope detection in monocytes, Metastasis-associated proteins, Non-canonical pathway, EDIM-blood test, Early detection and diagnosis, Genetic BRCA2 insufficiency, Circulating DNA methylation, Asymptomatic cancer, GSH redox, Estrogen-signaling, Lung cancer prevention, Quality-adjusted life expectancy, Out-of-pocket money, Ca2+ homeostasis, Calmodulin antagonists, Renal excretion, Serine-threonine inhibitors, Inducing RIP1, RIP3 dependent necroptosis, Balloon cytology, Epithelial density, Fusion protein EWS/WT1, Murine embryonic fibroblasts, Phosphatidylinositol kinase, Searching reliable, Cytotoxic T lymphocyte-mediated lysis, Protein cancer biomarkers, Breast fluid secretome, SMAD3 transcriptional activity, Paradoxical pro-tumorigenic, ER-receptor, PR-receptor, Increased surveillance, Multicenter analysis, Charlson comorbidity score, HER2 amplification, Urothelial carcinoma of the bladder, Yes-associated protein 1, Wnt signaling transcriptional complex, Interlukin 8, Claudin-1, Abnormal expression, Baculoviral inhibitor, Prostate zones, MiRNA expression, Transition zone, Especially squamous-cell carcinoma, DEK protein, Numerous human malignancies, Tumor cells capable, ALDH+ phenotype, Scattering properties, Cells surrounding, Terminal end bud, Growth factor receptor, Pneumonia acquired during radiotherapy, Including mesothelioma, Certain comorbidities, Hematopoietic malignancy, Dismal outcome, Disease monitoring, Predominantly fair-skinned, Cell adhesion-related glycoproteins MUC-1, Abdominal cancers, Nuclear factor rythroid 2-related factor 2, Radiotherapy fraction, Exogenous stresses, TNF-related apoptosis inducing ligand, Therapeutic options, Doxorubicin either, Recombinant granulocyte-colony stimulating factor, Docetaxel chemotherapy, Intensified neoadjuvant radiochemotherapy, Cancer related survival, Global hypomethylation, Plasma S-adenosylmethionine, Trained dogs, Including physical, Consequently increasing survival, Direct bisulfite sequencing, Temporal lobe injury, Acid-prepared mesoporous silica, Malignant mesotheliomas, Chemoresistant tumors, Basal phenotype, Mammary adenocarcinoma, Pain diagnosis, Luminex assay, Biomarker validation, High mammographic density, Integrin alpha3, Integrin beta4, Multiplex analysis, Adherence rates, Definite chemoradiotherapy, Complete histological response, Low cell counts, Operative morbidity, M2 macrophages contribute, Serum metabolite biomarkers, Tumor proliferation, Symptom index, Tumor incidence, Ovarian origin, HPV-mediated transformation, Differentiation resistant phenotype, Periampullary adenocarcinomas, Distal bile duct, Duodenal adenocarcinoma, Embryologic origin, Lanreotide autogel, Antiproliferative effect, Transcribed ultra-conserved regions, Ultra-conserved regions, ATRA-responsive cell lines, Excision repair cross-complementation group 1, Hepatocyte nuclear factor 4alpha, Thymosin β10, Bone morphogenetic protein 4, EGFR 3′ untranslated region, Matrigel provides, CRC cell lines, Adrenocortical carcinomas, Small-scale randomized clinical trial, TP53 gene, Promote malignant, Oncogenic factors secreted, Tumor cell-secreted factors, Ubiquitin-conjugating enzyme 2C, Absolute rates, Presenting estimates, Non-coding RNA over-expressed, Potential disease-specific biomarker, Corticotropin releasing factor, Deleted in liver cancer 1, Growing rapidly, Proximal tubules, CRHBP protein, Cholinergic agonist, Detached mindfulness, Mesothelial origin, Co-morbidity, Tankyrase inhibitors, β-catenin mutations, Kinase and phosphatase inhibitors, Early pneumothorax, ALK rearranged lung adenocarcinoma, Bahraini women, Scarce information, Certain breakdown, Tumor blood vessels, Hypoxia occurs, Certain molecular features, Significant hypoxia, NFκB pathways, Malignant peripheral nerve sheath tumor, Invasive phenotype, Imatinib mesylate inhibits cell growth, Resistant cell lines, Crypt growth factors, Receptor-β, Racial disparity, Lymphomas including Hodgkin’s, Odontogenic Ameloblast-associated Protein, Vascular endothelial growth, Carcinogenic exposure, Neoplastic tissues, Haematopoietic malignancies, Potential carcinogens, Cellular growth, Acute skin damage, Cisplatin combination, Individual’s susceptibility, Single-locus analysis, Estrogen receptor pathway, Gallbladder toxicity, Soy phytoestrogens, Refractory to aromatase inhibitor, Including cholecystitis, Recurrent mutations, IGF1R signaling, Metabolite equol, Overall meta-analysis, Biliary colic, Asturian population, Non-steroidal aromatase inhibitor, Bone neoplasm, Gallbladder enlargement, High-grade osteosarcoma, Invasive cervical carcinoma, Follicle-stimulating hormone receptor, High-grade astrocytomas, Cox-2 inhibitor celecoxib, Aggressive malignant brain tumors, Skeletal mineralization, Gastric cardia adenocarcinoma, Promoter’s methylation prior, PDAC-phenotypes, Anaplastic lymphoma kinase gene, Epithelial capsules, Long interspersed nuclear element-1 endonuclease, Q methodology, GCRG213 protein, Non-disrupted capsule, Sexual wellbeing, Tight junction protein, NOTCH1 mutations, Src kinase, Mechanism of inhibition, Anti-VEGF antibody, Separating patients treated, Piagnostic accuracy, Epidermal barrier function, Treating urothelial cancer, Claudin 1 protein, Describe factors, Multiple signal pathways, Anti-bacterial prophylaxis, 1-hydroxypyrene glucuronide, Diffuse reflectance imaging, Extracellular matrix structure, Nuclear changes, Proliferation assays, Rhabdoid tumors, Chemotherapy necessitating, HDAC-inhibitors plus fenretinide, Aggressive neoplasm, Accurate prognostic, Prognostic tumor biomarkers, Increasing incidence rate, Complete prevalence, 70-gene signature, Salted fish consumption, Vitamin D analogs, Metastasis-related genes, G2/M DNA-damage checkpoint, SIRT1 up-regulation, Complex health problems, Acquire mesenchymal, Ultrasonic spectrum analysis, Unnecessary chemotherapy, Biologically distinct subgroups, Young breast cancer, Underlying clinical significance, ESCC cell growth, Musculoskeletal sarcoma, NDRG2-negative patients, Neural-cadherin, Tissue morphogenesis, Metastasis-free survival rate, Seborrheic keratosis, Epigenetic reprogramming, Pluripotency-related pathways, Frizzled-8, Wnt-2, Germ line mutations, Plausible candidate, Simultaneous modulated accelerated radiotherapy, Prokaryotic organisms, Boost technique, Low self- motivation, N-terminal methionine excision, Cervical lymph nodes, Human mitochondrial peptide deformylase, Transcription activity, Epstein-Barr virus–associated malignancy, Definitive treatment eventually, Radioresistant NPC cell line, Molecular therapeutic, Hypoxic incubator, Partial oxygen deprivation, Decreased oxygenation, Low-dose, Excluding nasopharynx, Obesity-associated gene, Sexual hygiene, Cancer-associated anemia, Non-thyroidal illness syndrome, DNA-damaging drugs, Low hemoglobin, Roslin 2, Therapeutically challenging malignancies, First-degree relatives, Cancer patient survival, Dual-luciferase assays, Anthracycline treatment, Hematopoietic factor, Individual cancers, Metropolitan areas, BRCA1/2 mutation carriers, Haematopoietic tissues, African men, Melanoma therapy, External beam RT, Mutated BRAF gene, Humanized KS-interleukin-2, Immunologic activity, Aggressive tumor, Hemithoracic radiation, Pathological pregnancy, Choriocarcinoma via regulation, Anti-apoptotic protein Bcl-2, Potentially interesting diagnostic factor, Gestational trophoblastic tumor, Choriocarcinoma cell lines, Osteolytic bone disease, Therapeutics entering, Chronic administration, Residual cancer cells, Gefitinib maintenance treatment, Cytostatic concentrations, Metastatic cancer cells, Gene electrotransfer, Promoting oncogenicity, HAT inhibitor, Tumor treatment, Radiation treatment of sarcomas, Acetylated H4K16, HER targeted therapy, Trimethylated H4K20, Luminal subtype, Microarray gene expression analysis, Chemotherapeutic failure, EGFR ligands, Adjacent nonmalignant, PI3K gene mutations, Gene over-expression, Eloquent tumor, Anaplastic astrocytomas, Primary invasive breast cancer tumors, Matricellular glycoprotein, Non-serosa-invasive, Pediatric leukemia, Congenital acute lymphoblastic leukemia, Cytokine secretion profiles, NF-κB signaling pathway, Rib fracture, Chest wall injury, Class III beta-tubulin, Matrix metalloproteinase 14, Specificity protein 1